Effat Davoudi-Monfared

665 total citations
14 papers, 450 citations indexed

About

Effat Davoudi-Monfared is a scholar working on Infectious Diseases, Neurology and Surgery. According to data from OpenAlex, Effat Davoudi-Monfared has authored 14 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Neurology and 3 papers in Surgery. Recurrent topics in Effat Davoudi-Monfared's work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Long-Term Effects of COVID-19 (4 papers). Effat Davoudi-Monfared is often cited by papers focused on COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Long-Term Effects of COVID-19 (4 papers). Effat Davoudi-Monfared collaborates with scholars based in Iran and Germany. Effat Davoudi-Monfared's co-authors include Hossein Khalili, Mir Saeed Yekaninejad, Hamid Rahmani, Ladan Abbasian, Mohamadreza Salehi, Mahboubeh Hajiabdolbaghi, Mohammad Reza Fazeli, Fereshteh Ghiasvand, Sirous Jafari and Mojtaba Mojtahedzadeh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and International Immunopharmacology.

In The Last Decade

Effat Davoudi-Monfared

10 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Effat Davoudi-Monfared Iran 7 362 204 54 51 41 14 450
Erich Pawelka Austria 12 443 1.2× 159 0.8× 76 1.4× 35 0.7× 32 0.8× 28 590
Lorenzo Bertolino Italy 9 205 0.6× 95 0.5× 99 1.8× 14 0.3× 22 0.5× 26 350
Zhiguo Zhou China 10 165 0.5× 87 0.4× 52 1.0× 24 0.5× 45 1.1× 16 289
Dan Jiang China 9 195 0.5× 116 0.6× 36 0.7× 27 0.5× 48 1.2× 23 382
Mohamadreza Salehi Iran 4 307 0.8× 152 0.7× 43 0.8× 38 0.7× 33 0.8× 5 414
Ciro Canetta Italy 9 83 0.2× 75 0.4× 55 1.0× 28 0.5× 46 1.1× 33 410
Jiake Tang China 7 221 0.6× 69 0.3× 99 1.8× 17 0.3× 21 0.5× 22 407
Zakariya Kashour Canada 8 245 0.7× 143 0.7× 45 0.8× 11 0.2× 30 0.7× 8 342
Haytham Tlayjeh Saudi Arabia 9 276 0.8× 163 0.8× 51 0.9× 10 0.2× 40 1.0× 19 397

Countries citing papers authored by Effat Davoudi-Monfared

Since Specialization
Citations

This map shows the geographic impact of Effat Davoudi-Monfared's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Effat Davoudi-Monfared with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Effat Davoudi-Monfared more than expected).

Fields of papers citing papers by Effat Davoudi-Monfared

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Effat Davoudi-Monfared. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Effat Davoudi-Monfared. The network helps show where Effat Davoudi-Monfared may publish in the future.

Co-authorship network of co-authors of Effat Davoudi-Monfared

This figure shows the co-authorship network connecting the top 25 collaborators of Effat Davoudi-Monfared. A scholar is included among the top collaborators of Effat Davoudi-Monfared based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Effat Davoudi-Monfared. Effat Davoudi-Monfared is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Davoudi-Monfared, Effat, et al.. (2025). Rechallenge of Polymyxins After Incidence of Neurotoxicity: A Risk or a Second Chance?. American Journal of Therapeutics. 33(1). e71–e74.
2.
Salehi, Mohammadreza, Jon Salmanton‐García, Mohammad Abdollahı, et al.. (2025). The Value of the Galactomannan Test in Diagnosing COVID-19–Associated Pulmonary Aspergillosis: A Review. Iranian journal of pathology. 20(2). 142–151.
3.
Davoudi-Monfared, Effat, et al.. (2025). Emphysematous pyelonephritis due to Candida albicans in a diabetic patient: A case report. Urology Case Reports. 59. 102960–102960.
4.
Davoudi-Monfared, Effat, et al.. (2023). Effect of Famotidine on COVID-19: Killing Virus or Opposing ARDS?. Pulmonary Therapy. 9(2). 173–175. 1 indexed citations
5.
Davoudi-Monfared, Effat, et al.. (2022). Management of a critically ill patient with COVID-19-related fulminant myocarditis: A case report. Respiratory Medicine Case Reports. 36. 101611–101611. 7 indexed citations
6.
Davoudi-Monfared, Effat, et al.. (2022). Remdesivir Administration in COVID-19 Patients With Renal Impairment: A Systematic Review. American Journal of Therapeutics. 29(5). e520–e533. 7 indexed citations
7.
Abbasian, Ladan, Effat Davoudi-Monfared, Hossein Khalili, et al.. (2021). Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial. Pharmacological Reports. 74(1). 229–240. 40 indexed citations
8.
Davoudi-Monfared, Effat, et al.. (2021). The effect of midodrine on lactate clearance in patients with septic shock: a pilot study. Journal of Comparative Effectiveness Research. 10(8). 673–683. 3 indexed citations
9.
Rahmani, Hamid, Effat Davoudi-Monfared, Hossein Khalili, et al.. (2020). Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir. DARU Journal of Pharmaceutical Sciences. 28(2). 625–634. 17 indexed citations
10.
Rahmani, Hamid, et al.. (2020). Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial. International Immunopharmacology. 88. 106903–106903. 120 indexed citations
11.
Davoudi-Monfared, Effat, Hamid Rahmani, Hossein Khalili, et al.. (2020). A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19. Antimicrobial Agents and Chemotherapy. 64(9). 228 indexed citations
12.
Davoudi-Monfared, Effat, et al.. (2019). A Case Series of Severe Hyperammonemia Encephalopathy Related to Valproate: Can Antipsychotics Increase the Risk?. Iranian Journal of Psychiatry. 14(3). 248–252. 5 indexed citations
13.
Davoudi-Monfared, Effat, et al.. (2018). The threat of carbapenem-resistant gram-negative bacteria in a Middle East region. Infection and Drug Resistance. Volume 11. 1831–1880. 22 indexed citations
14.
Davoudi-Monfared, Effat, et al.. (2017). Citalopram induced nightmare in an elderly man: a case-report. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erich Pawelka Breakdown of academic impact, for papers by Lorenzo Bertolino Breakdown of academic impact, for papers by Zhiguo Zhou Breakdown of academic impact, for papers by Dan Jiang Breakdown of academic impact, for papers by Mohamadreza Salehi Breakdown of academic impact, for papers by Ciro Canetta Breakdown of academic impact, for papers by Jiake Tang Breakdown of academic impact, for papers by Zakariya Kashour Breakdown of academic impact, for papers by Haytham Tlayjeh
Rankless by CCL
2026